Authors


Jessilin Quint, OD, MBA, MS, FAAO

Latest:

AOA 2023: Taking a modern approach to dry eye

Jessilin Quint, OD, MBA, MS, FAAO, shares the latest and greatest in the world of dry eye, from new technology to how clinicians can start in on dry eye therapy today.


Mark Bullimore, PhD, MCOptom

Latest:

EyeCon 2023: Tackling the issue of myopia management

Mark Bullimore, MCOptom, PhD, FAAO, discussed myopia control in a panel at EyeCon 2023, highlighting evidence-based treatments, myopia's impact on visual impairment, and a multidisciplinary conversation involving optometrists and ophthalmologists to address the growing issue of myopia management.


Dennis P. Pardo, OD, MPH, FAAO, LCSW

Latest:

AAOpt 2023: Plenary: Mental health and optometry

Bringing awareness, understanding, and embracing mental health care gives clinicians the space to best support and empower their patients, as well as themselves.


Emily Aristizabal

Latest:

Patient experiences sudden decrease in vision

Imaging shows optic disc swelling and retinal nerve fiber layer thickening


Catherine L. Heyman, OD, FAAO, FCOVD

Latest:

Tips on creating a space, treating patients with special needs

Catherine L. Heyman, OD, FAAO, FCOVD, shares highlights from her AOA 2022 presentation, "Evaluation and Management of Patients with Special Needs."


Thomas V. Johnson, MD, PhD

Latest:

EyeCon 2023: Pearls for monitoring intraocular pressure at home and in the office

Real-time insights into fluctuations enhance glaucoma care and understanding of vision risk.


Adler
Richard A. Adler, MD, FACS

Latest:

Viewing ptosis through a biopsychosocial lens

Low-lying lids affect much more than patients' visual field, with implications for visual quality and their self-esteem.


Bi Yang

Latest:

The latest and greatest in myopia control

Control measures in China are ahead of US measures.


Brenda Montecalvo, OD

Latest:

Addressing symptom relief of optic neuritis in multiple sclerosis

Contoured prism lenses may resolve symptoms such as neck, shoulder, and head pain.


Stephen Cohen, OD

Latest:

Tackling the problem of contact lens dropout from presbyopia

With advanced, easy-to-fit multifocal lens technologies, patients don’t need to compromise



Jim Sluck

Latest:

Sight Sciences' fair access campaign aims for insured access to heat and expression therapy for meibomian gland dysfunction

Jim Sluck, VP of Marketing for Sight Sciences' TearCare, shares the impetus behind the company's fair access campaign.


Emily Rich

Latest:

Impact of vision impairment on children’s mental health

Studies conducted with Orbis International conclude positive mental health and academic improvements of children provided appropriate eye care and glasses, filling important research gaps and providing essential guidance for future interventions and research.


Rhea Magee, OD

Latest:

NOA 2023: Insights and lessons from a pediatric patient case

At NOA 2023 in Fort Lauderdale, Florida, Rhea Magee, OD, presented a pediatric patient case as part of the Resident Grand Rounds.


Maria K. Walker, OD, PhD

Latest:

Basic and beyond: technology for every level of scleral lens management

How to fit lenses with simple devices and when to expand your armature.


John Berdahl, MD

Latest:

ASCRS 2023: Aurion clinical trials of endothelial cell therapy injection

John Berdahl, MD, discussed the Aurion clinical trials of endothelial cell therapy injection at the 2023 ASCRS annual meeting in San Diego.


Carla Calizaire

Latest:

AAOpt 2023: Raising awareness for vision health

Optometry Times sat down with Carla Calizaire, Global Leader of Diversity Inclusion for Johnson and Johnson Med Tech to go in depth about the Vision Made Possible and Sight for Kids campaign.


Sydney M Crago, Editor, Modern Retina

Latest:

Data and Safety Monitoring Board for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410

The Phase 1/2 study includes a dose-escalation phase of the study featuring 3 cohorts each one receiving either a low, medium, or high dose of OCU410.



Lisa Hornick, OD

Latest:

AAOpt 2023: What's new in dry eye?

Lisa Hornick, OD, MBA, FAAO, chats about her AAOpt presentations, "Dry Eye Jeopardy" and "Sunny with a Chance of Tears of Tears: What's in the Forecast for Ocular Surface Dryness Therapies."


Houman Hemmati, MD, PhD

Latest:

AAOpt 2022: CHAMP study shows positive top-line results for treating myopia

The CHAMP phase 3 study shows strong safety and efficacy of NVK002 for the treatment of myopia.


Samantha Rosen, OD

Latest:

The complicated ins and outs of pediatric glaucoma

Pediatric glaucoma, although rare, can cause irreversible vision loss and leave children visually impaired if not treated timely and adequately.


David Yang, OD, FAAO

Latest:

How diabetes and glaucoma intersect

Consider the impact of diabetes on management of patients with glaucoma


Janelle Davison, OD

Latest:

Offer advanced patient care by bundling services

Combining products and resources in creative ways can help grow your business.


Donna L. Shotwell, OD

Latest:

Meeting the need: Screening parameters for presbyopia-correcting drops

Doctors should consider a few key points before writing a prescription.


Alan Peaslee, OD, MS

Latest:

Handling comorbidities prior to surgery

Addressing issues prior to referral will facilitate the referral process and enable more efficient care for your patient as well as maximize outcomes.


Jaclyn L. Kovach, MD

Latest:

Is complement therapy the path forward for geographic atrophy?

Clinical benefit of complement inhibition has been demonstrated in clinical trials, but there are possible consequences to consider.




Shani Reich, MD

Latest:

Adjunct role for Dextenza insert in allergic conjunctivitis?

Regarding both the amount and speed of symptom improvement, patients were more satisfied with the insert compared with the topical steroid, but there was no statistically significant difference vs the topical antihistamine in terms of satisfaction.

© 2024 MJH Life Sciences

All rights reserved.